Literature DB >> 8139043

Negative regulation of the 5' long terminal repeat (LTR) by the 3' LTR in the murine proviral genome.

M A Gama Sosa1, D H Rosas, R DeGasperi, E Morita, M R Hutchison, R M Ruprecht.   

Abstract

To assess the influence of the 3' long terminal repeat (LTR) on the promoter/enhancer activity of the 5' LTR, a set of isogenic retroviral vectors differing only in the U3 region of the 3' LTR was constructed. These U3 elements were derived from viruses with different tissue tropism. The 5' LTR originated from Moloney murine leukemia virus and directed the transcription of a reporter gene (chloramphenicol acetyltransferase [CAT] gene), giving rise to plasmids of the general configuration LTR-CAT-LTR'. Following transfection of these chimeric constructs into various cell types, the CAT activity in a given cell line was inversely related to the activity of the downstream U3 region when used in a single-LTR construct in that cell type, indicating negative regulation of the 5' LTR by the chimeric 3' LTR'. Our data indicate that a highly active 3' LTR interferes with gene expression from the 5' LTR. Potential mechanisms for this down-regulation are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8139043      PMCID: PMC236743     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  RNA complementary to the genome of RNA tumor viruses in virions and virus-producing cells.

Authors:  E Stavnezer; G Ringold; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1976-10       Impact factor: 5.103

2.  Biochemical transfer of single-copy eucaryotic genes using total cellular DNA as donor.

Authors:  M Wigler; A Pellicer; S Silverstein; R Axel
Journal:  Cell       Date:  1978-07       Impact factor: 41.582

Review 3.  Erythroleukemic differentiation.

Authors:  P A Marks; R A Rifkind
Journal:  Annu Rev Biochem       Date:  1978       Impact factor: 23.643

4.  The role of MuLV receptors on T-lymphoma cells in lymphoma cell proliferation.

Authors:  M S McGrath; E Pillemer; D Kooistra; I L Weissman
Journal:  Contemp Top Immunobiol       Date:  1980

5.  Establishment and characterization of BALB/c lymphoma lines with B cell properties.

Authors:  K J Kim; C Kanellopoulos-Langevin; R M Merwin; D H Sachs; R Asofsky
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

6.  Supercoil sequencing: a fast and simple method for sequencing plasmid DNA.

Authors:  E Y Chen; P H Seeburg
Journal:  DNA       Date:  1985-04

7.  Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat.

Authors:  J Sodroski; C Rosen; F Wong-Staal; S Z Salahuddin; M Popovic; S Arya; R C Gallo; W A Haseltine
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

8.  Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state.

Authors:  G S Payne; S A Courtneidge; L B Crittenden; A M Fadly; J M Bishop; H E Varmus
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Mechanism of activation of the mouse c-mos oncogene by the LTR of an intracisternal A-particle gene.

Authors:  M Horowitz; S Luria; G Rechavi; D Givol
Journal:  EMBO J       Date:  1984-12-01       Impact factor: 11.598

View more
  2 in total

1.  Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site.

Authors:  A Choulika; V Guyot; J F Nicolas
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

2.  B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.

Authors:  J Lovmand; A B Sorensen; J Schmidt; M Ostergaard; A Luz; F S Pedersen
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.